Clinical implications of acute myeloid leukemia presenting as myeloid sarcoma

Hematological Oncology

Volumn 30, Issue 1, 2012, Pages 34-40

  Avni, Batia ^a   Rund, Debora ^a   Levin, Moshe ^a   Grisariu, Sigal ^a   Ben Yehuda, Dina ^a   Bar Cohen, Sara ^a   Paltiel, Ora ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Acute myeloid leukemia; Hematopoietic stem cell transplantation; Myeloid sarcoma; Prognostic factors; Radiotherapy

Indexed keywords

ANTILEUKEMIC AGENT; NUCLEOPHOSMIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW CELL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOGENETICS; DEATH; FEMALE; FOLLOW UP; GENDER; GRANULOCYTIC SARCOMA; HAZARD RATIO; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; KARYOTYPE; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MALE; MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; POLYCYTHEMIA VERA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOCYTOSIS;

ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SARCOMA, MYELOID; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84858156517     PISSN: 02780232     EISSN: 10991069     Source Type: Journal    
DOI: 10.1002/hon.994     Document Type: Article

References (19)

1. Jaffe ES, Harris NL, Stein H, Vardiman JW. Pathology and genetics. Tumors of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, 2001.
2. Neiman RS, Barcos M, Berard C, et al. Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases. Cancer 1981; 48: 1426-1437.
3. Byrd JC, Weiss RB, Arthur DC, et al. Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): Results from cancer and leukemia group B 8461. J Clin Oncol 1997; 15: 466-475.
4. Roth MJ, Medeiros LJ, Elenitoba-Johnson K, Kuchnio M, Jaffe ES, Stetler-Stevenson M. Extramedullary myeloid cell tumors. An immunohistochemical study of 29 cases using routinely fixed and processed paraffin-embedded tissue sections. Arch Pathol Lab Med 1995; 119: 790-798.
5. Paydas S, Zorludemir S, Ergin M. Granulocytic sarcoma: 32 cases and review of the literature. Leuk Lymphoma 2006; 47: 2527-2541.
6. Tallman MS, Hakimian D, Shaw JM, et al. Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia, J Clin Oncol 1993;11: 690-697.
7. Tsimberidou AM, Kantarjian HM, Estey E, et al. Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy. Leukemia 2003; 17: 1100-1103.
8. Yamauchi K, Yasuda M. Comparison in treatments of nonleukemic granulocytic sarcoma: report of 2 cases and a review of 72 cases in the literature. Cancer 2002; 94: 1739-1746.
9. Pileri SA, Ascani S, Cox MC, et al. Myeloid sarcoma: clinicopathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia 2007; 21: 340-350.
10. Rund D, Cohen S. The frequency of FLT3 rearrangements in acute myeloid leukemia is variable among different ethnic groups. Presented at the 7th European Hematology Association Meeting, Florence, Italy, June 2002 (Poster). Hematol J 2002; 3(Suppl1): 227.
11. Breccia M, Mandelli F, Petti MC, et al. Clinico-pathological characteristics of myeloid sarcoma at diagnosis and during follow-up: report of twelve cases from a single institution. Leuk Res 2004; 28: 1165-1169.
12. Tsimberidou AM, Kantarjian HM, Wen S, et al. Myeloid sarcoma is associated with superior event free survival compared with acute myeloid leukemia. Cancer 2008; 113: 1370-1378.
13. Chevallier P, Mohty M, Michel G, et al. Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TC. J Clin Oncol 2008; 26: 4940-4943.
14. Lan TY, Lin DT, Tien HF, et al. Prognostic factors of treatment outcomes in patients with granulocytic sarcoma. Acta Haematol 2009; 122: 238-246.
15. Byrd JC, Edenfield W, Shields DJ, Dawson NA. Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review. J Clin Oncol 1995; 13: 1800-1816.
16. Falini B, Lenze D, Hasserjian R, et al. Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas. Leukemia 2007; 21(7): 1566-1570.
17. Ansari-Lari MA, Yang CF, Tinawi-Aljundi R, et al. FLT3 mutations in myeloid sarcoma. Br J Haematol 2004 Sep; 126(6): 785-791.
18. Fujieda A, Nishii K, Tamaru T, et al. Granulocytic sarcoma of mesentery in acute myeloid leukemia with CBFB/MYH11 fusion gene but not inv (16) chromosome: case report and review of literature. Leuk Res 2006; 30: 1053-1057.
19. Stefanidakis M, Karjalainen K, Jaalouk DE, et al. Role of leukemia cell invadosome in extramedullary infiltration. Blood 2009; 114(14): 3008-3017.